Enzo Therapeutics of Farmingdale, New York, has filed a very broad patent on
the idea of using treeshrews instead of chimpanzees in medical testing (EP
1068799). The firm says that studies of HIV and human lymphotrophic T-cell
leukaemia have so far relied on chimps because they are the only animal that
develops similar symptoms to humans. They are also an endangered species and
very expensive to breed, says Enzo. But it says the treeshrew Tupaia
belangeri, which is found over a large area of Asia, is a much better model
for human diseases than chimps and has a shorter lifespan, so they can easily be
bred in large numbers.
More from New Scientist
Explore the latest news, articles and features
Technology
Test moderators use AI-generated writing to judge literacy standards
News
Technology
We should decide how AI shapes the future, not tech firms
Comment
Technology
Quantum voting could make elections more secure
News
Technology
DeepMind AI gives an extra day of warning ahead of deadly cyclones
News
Popular articles
Trending New Scientist articles